Cancer Chemotherapy and Pharmacology

, Volume 69, Issue 1, pp 207–213 | Cite as

Montelukast attenuates side effects of cisplatin including testicular, spermatological, and hormonal damage in male rats

  • Ali Beytur
  • Osman Ciftci
  • Fatih Oguz
  • Hakan Oguzturk
  • Fethi Yılmaz
Original Article


In the current study, the protective effect of montelukast (ML) on cisplatin induced reproductive toxicity in rats was investigated. Twenty-eight rats were equally divided into four groups; first group was kept as control. In the second group, ML was orally administered at the dose of 10 mg/kg/day for 10 days. In the third group, CP was intraperitoneally administered at the dose of 7 mg/kg a single injection, and in fourth group, CP and ML were given together at the same doses. Although CP induced oxidative stress via significant increase in the formation of TBARS, it caused a significant decline in the levels of GSH, CAT, GPx, and SOD in rats. In contrast, ML prevents these effects of CP through cause an increase in GSH, CAT, GPx, and SOD levels and a decrease in formation of TBARS. In addition, sperm motility and serum testosterone levels significantly decrease and histopathological damage increases with CP treatment. However, the effects of CP on sperm motility, serum testosterone level, oxidative and histopathological changes are eliminated by ML treatment. In conclusion, the current study demonstrated that the reproductive toxicity caused by CP may be prevented by ML treatment. Thus, it was judged that co-administration of ML with CP may be useful to attenuate the negative effects of CP on male reproductive system.


Cisplatin Montelukast Reproductive toxicity Testosterone Oxidative damage Sperm quality 


  1. 1.
    Lirdi LC, Stumpp T, Sasso-Cerri E, Miraglia M (2008) Amifostine protective effect on cisplatin-treated rat testis. Anat Rec (Hoboken) 291:797–808CrossRefGoogle Scholar
  2. 2.
    Ahmed EA, Omar HM, Elghaffar SKH, Ragb SM, Nasser AY (2011) The antioxidant activity of vitamin C, DPPD and l-cysteine against cisplatin-induced testicular oxidative damage in rats. Food Chem Toxicol 49:1115–1121PubMedCrossRefGoogle Scholar
  3. 3.
    Ilbey YO, Ozbek E, Cekmen M, Simsek A, Otunctemur A, Somay A (2009) Protective effect of curcumin in cisplatin-induced oxidative injury in rat testis: mitogen-activated protein kinase and nuclear factor-kappa B signaling pathways. Hum Reprod 24:1717–1725PubMedCrossRefGoogle Scholar
  4. 4.
    Amin A, Hamza AA (2006) Effects of roselle and ginger on cisplatin-induced reproductive toxicity in rats. Asian J Androl 8:607–612PubMedCrossRefGoogle Scholar
  5. 5.
    Silici S, Ekmekcioglu O, Eraslan G, Demirtas A (2009) Antioxidative effect of royal jelly in cisplatin-induced testes damage. Urology 74:545–551PubMedCrossRefGoogle Scholar
  6. 6.
    Fung C, Vaughn DJ (2011) Complications associated with chemotherapy in testicular cancer management. Nat Rev Urol 8:213–222PubMedCrossRefGoogle Scholar
  7. 7.
    Ateşşahin A, Karahan I, Türk G, Gür S, Yilmaz S, Ceribaşi AO (2006) Protective role of lycopene on cisplatin-induced changes in sperm characteristics, testicular damage and oxidative stress in rats. Reprod Toxicol 21:42–47PubMedCrossRefGoogle Scholar
  8. 8.
    Al Vawda (1994) Effect of testosterone on cisplatin-induced testicular damage. Arch Androl 32:53–57CrossRefGoogle Scholar
  9. 9.
    Muthuraman A, Sood S (2010) Antisecretory, antioxidative and antiapoptotic effects of montelukast on pyloric ligation and water immersion stress induced peptic ulcer in rat. Prostaglandins Leukot Essent Fat Acids 83:55–60CrossRefGoogle Scholar
  10. 10.
    Drazen JM, Israel E, O’Byrne PM (1999) Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 340:197–206PubMedCrossRefGoogle Scholar
  11. 11.
    Dengiz GO, Odabasoglu F, Halici Z, Cadirci E, Suleyman H (2007) Gastroprotective and antioxidant effects of montelukast on indomethacin-induced gastric ulcer in rats. J Pharmacol Sci 105:94–102PubMedCrossRefGoogle Scholar
  12. 12.
    Canbay E, Agachan B, Ozturk T, Giris M, Asoglu O, Balik E, Bugra D (2010) Dual inhibition of wound healing and oxidative process by montelukast in experimental colon anastomoses. Surg Innov 17:248–255PubMedCrossRefGoogle Scholar
  13. 13.
    Ozkan E, Yardimci S, Dulundu E, Topaloğlu U, Sehirli O, Ercan F, Velioğlu-Oğünç A, Sener G (2010) Protective potential of montelukast against hepatic ischemia/reperfusion injury in rats. J Surg Res 159:588–594PubMedCrossRefGoogle Scholar
  14. 14.
    Ozturk H, Ozturk H, Gideroglu K, Terzi H, Bugdayci G (2010) Montelukast protecs against testes ischemia/reperfusion injury in rats. Can Urol Assos J 4:174–179Google Scholar
  15. 15.
    Ilbey YO, Ozbek E, Simsek A, Otunctemur A, Cekmen M, Somay A (2009) Potential chemoprotective effect of melatonin in cyclophosphamide- and cisplatin-induced testicular damage in rats. Fertil Steril 92:1124–1132PubMedCrossRefGoogle Scholar
  16. 16.
    Yagi K (1998) Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol 108:101–106PubMedGoogle Scholar
  17. 17.
    Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25:192–205PubMedCrossRefGoogle Scholar
  18. 18.
    Sun Y, Oberley LW, Li YA (1988) Simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500PubMedGoogle Scholar
  19. 19.
    Aebi H (1974) Catalase. In: Bergmeyer HU (ed) In methods of enzymatic analysis. Academic Press, NY, pp 673–677Google Scholar
  20. 20.
    Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169PubMedGoogle Scholar
  21. 21.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RI (1951) Protein measurement with folin phenol reagent. J Biol Chem 193(1):265–275PubMedGoogle Scholar
  22. 22.
    Ciftci O, Aydin M, Ozdemir I, Vardi N (2011a) Quercetin prevents 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced testicular damage in rats. Andrologia. doi: 10.1111/j.1439-0272.2010.01126
  23. 23.
    Ciftci O, Ozdemir İ, Aydin M, Beytur A (2011b) Beneficial effects of chrysin on the reproductive system of adult male rats. Andrologia. doi: 10.1111/j.1439-0272.2010.01127
  24. 24.
    Sawhney P, Giammona CJ, Meistrich ML, Richburg JH (2005) Cisplatin-induced long-term failure of spermatogenesis in adult C57/Bl/6J mice. J Androl 26:136–145PubMedGoogle Scholar
  25. 25.
    Ciftci O, Ozdemir I, Vardi N, Gurbuz N (2010) Novel platinum-N-heterocyclic carbene complex is more cardiotoxic than cis-platin in rats. Hum Exp Toxicol. doi: 10.1177/096032711039006
  26. 26.
    Ateşşahin A, Sahna E, Türk G, Ceribaşi AO, Yilmaz S, Yüce A, Bulmuş O (2006) Chemoprotective effect of melatonin against cisplatin-induced testicular toxicity in rats. J Pineal Res 41:21–27PubMedCrossRefGoogle Scholar
  27. 27.
    Montjean D, Ménézo Y, Benkhalifa M, Cohen M, Belloc S, Cohen-Bacrie P, de Mouzon J (2010) Malonaldehyde formation and DNA fragmentation: two independent sperm decays linked to reactive oxygen species. Zygote 18:265–268PubMedCrossRefGoogle Scholar
  28. 28.
    Chainy GBN, Samantaray S, Samanta L (1997) Testosterone-induced changes in testicular antioxidant system. Andrologia 29:343–349PubMedCrossRefGoogle Scholar
  29. 29.
    Cuciureanu M, Căruntu ID, Păduraru O, Stoica B, Jerca L, Crauciuc E, Nechifor M (2009) The protective effect of montelukast sodium on carbon tetrachloride induced hepatopathy in rat. Prostaglandins Other Lipid Mediat 88:82–88PubMedCrossRefGoogle Scholar
  30. 30.
    Schiller HJ, Reilly PM, Bulkley GB (1993) Tissue perfusion in critical illnesses. Antioxidant therapy. Crit Care Med 21:92–102CrossRefGoogle Scholar
  31. 31.
    Türk G, Ateşşahin A, Sönmez M, Ceribaşi AO, Yüce A (2008) Improvement of cisplatin-induced injuries to sperm quality, the oxidant-antioxidant system, and the histologic structure of the rat testis by ellagic acid. Fertil Steril 89:1474–1481PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Ali Beytur
    • 1
  • Osman Ciftci
    • 2
  • Fatih Oguz
    • 1
  • Hakan Oguzturk
    • 3
  • Fethi Yılmaz
    • 4
  1. 1.Faculty of Medicine, Department of UrologyUniversity of InonuMalatyaTurkey
  2. 2.Faculty of Pharmacy, Department of Pharmaceutical ToxicologyUniversity of InonuMalatyaTurkey
  3. 3.Faculty Medicine, Department of Emergency MedicineUniversity of InonuMalatyaTurkey
  4. 4.Elazig School of Health ScienceUniversity of FiratElazigTurkey

Personalised recommendations